WHO’S regional director says Europe facing more than 100 cases of Mpox per month, EU officials preventing public disclosures!

Mpox News: In a recent update from the World Health Organization (WHO), alarming news has emerged regarding the steady rise of Mpox cases across Europe.
https://uk.news.yahoo.com/warning-100-cases-mpox-found-111206041.html
 

WHO’S regional director says Europe facing more than 100 cases of Mpox per month,
EU officials preventing public disclosures!

The viral disease, formerly known as monkeypox, is now registering over 100 new cases every month on the European continent according to the WHO regional director for Europe.
 
This concerning trend has prompted renewed warnings from health officials and a call to action to curb the spread of the virus.
 
While most are the Clade 2 strains, there has also been clade I infections but it seems the EU officials and many governments in Europe are refusing to make public disclosures or for the media to report any Mpox News coverages about the emergence of such cases in Europe.
 
Sweden was the only European country to report about a case involving the clade I strain.
https://www.thailandmedical.news/news/mpox-clade-i-debuts-in-sweden-cases-expected-in-uk-next
 
However, it is also emerging that that disclosure was a mishap by certain health officials as the higher ups did not actually want the case to be disclosed!
 
Europe Faces Rising Mpox Infections
The WHO's latest briefing highlights a troubling situation in Europe, where Mpox continues to spread at an unsettling rate. Hans Kluge, the WHO Regional Director for Europe, confirmed during a media briefing that at least 100 new cases are being recorded monthly. This persistent increase in infections has led to growing fears among health authorities, particularly with recent cases emerging in Sweden and Pakistan. The possibility that the disease could also be present in the United Kingdom has further heightened concerns.
 
Kluge emphasized the critical need for a coordinated global response, stating, "We can and must tackle Mpox together. The choices we make now, whether to establish robust systems to control and eliminate Mpox globally or to enter another cycle of panic and neglect, will be a critical test for Europe and the world."
 
The Symptoms and Spread of Mpox
Mpox, a zoonotic disease caused by the Monkeypox virus, shares similarities with smallpox and can lead to a range of symptoms. Initial signs of infection include fever, headaches, muscle pains, backache, swollen lymph nodes, chills, fatigue, and joint pain. Typically, a rash appears one to five days after the onset of these symptoms, starting on the face before spreading to other parts of the body. In some cases, Mpox can cause pus-filled lesions and flu-l ike symptoms, which, while generally mild, can be fatal in certain instances.
 
The virus is primarily transmitted through close contact with an infected person or animal. The Centers for Disease Control and Prevention (CDC) notes that the virus can enter the body through broken skin, the respiratory tract, or mucous membranes such as the eyes, nose, and mouth.
 
Variants of Concern: Clade 1 and Clade 2
There are two main strains of the virus that have drawn attention from health officials. Clade 1, which is known for its severe symptoms, has caused significant concern due to its spread in the Democratic Republic of Congo and other regions. This strain can cause high fever, severe headaches, muscle aches, and extensive skin lesions, often leading to scarring. On the other hand, Clade 2 is typically associated with milder symptoms but continues to spread within specific communities, such as those involving men who have sex with men.
 
The WHO has highlighted the ongoing challenge of monitoring these variants, particularly Clade 1b, which has shown a propensity to spread more easily through routine close contact. Recent cases in Sweden, Pakistan and Argentina have been linked to this more transmissible strain, raising fears of a broader international outbreak.
 
Global Response and Continued Vigilance
As the number of cases continues to rise, global health experts are working tirelessly to understand and contain the virus. Professor Trudie Lang from Oxford University has underscored the difficulties faced by researchers in analyzing the rate of transmission, the severity of the disease, and the outcomes for those infected. "There are still a lot of unknowns. We're busting our guts to try to analyze the rate of transmission, the severity of the disease, outcomes, where the rash appears, how long it takes to be infectious - all of those things," she explained.
 
Meanwhile, Dr. Matshidiso Moeti, WHO Regional Director for Africa, emphasized the proactive measures being taken in response to the growing spread of the virus. "Significant efforts are already underway in close collaboration with communities and governments, with our country teams working on the frontlines to help reinforce measures to curb Mpox," she stated. The WHO is scaling up its efforts through coordinated international action to support countries in bringing the outbreaks to an end.
 
Mpox Beyond Europe: The African and Global Context
Mpox is not confined to Europe alone; the virus continues to affect multiple regions across Africa, where the disease was first identified. The Democratic Republic of Congo, in particular, has seen a significant surge in cases of the Clade 1b strain. Other African countries, including Burundi, Cameroon, Ghana, Kenya, and Nigeria, have also reported rising numbers of infections. The situation in Africa remains critical, with various countries declaring public health emergencies in response to the outbreaks.
 
The spread of the virus has also reached countries outside of Africa. Sweden recently confirmed its first case of the new deadly Mpox strain, following a person's return from an affected area in Africa. Pakistan has also reported suspected cases, raising concerns about the virus's potential spread in the region.
 
The Need for International Cooperation
The ongoing Mpox outbreak serves as a stark reminder of the importance of international vigilance and prompt public health interventions. As the virus continues to pose a significant threat to global health, the WHO's call for a unified global response has never been more urgent. The coming months will be crucial in determining whether the world can effectively contain and eventually eliminate Mpox or if it will face a prolonged battle against this emerging infectious disease.
 
For the latest Mpox News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-ivermectin-users-will-likely-suffer-severe-or-lethal-mpox-infection-due-to-diminished-interferon-gamma
 
https://www.thailandmedical.news/news/human-kidney-organoid-study-reveals-that-monkeypox-mpox-virus-can-infect-kidneys